Viveve Medical, Inc. Financial Statements — VIVE Stock

Income Statement	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y
Sales/Revenue/Turnover	6	5	5	1	1	1	1	- -	1	7	15	19	7	5	6
+ Sales & Services Revenue	6	5	5	1	1	1	1	- -	1	7	15	19	7	5	6
- Cost of Revenue	3	2	2	1	- -	1	1	- -	1	5	8	11	6	5	6
+ Cost of Goods & Services	3	2	2	1	- -	1	1	- -	1	5	8	11	6	5	6
Gross Profit	3	3	3	- -	- -	1	1	- -	- -	3	7	7	1	- -	1
+ Other Operating Income	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Operating Expenses	6	5	4	3	4	5	5	6	12	21	41	52	31	19	22
+ Selling, General & Admin	4	3	3	3	2	3	3	4	7	13	29	39	22	14	13
+ Research & Development	2	2	1	- -	1	2	2	1	5	8	12	14	9	5	10
+ Other Operating Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income (Loss)	-3	-2	-2	-3	-3	-4	-5	-6	-12	-19	-34	-45	-30	-18	-22
- Non-Operating (Income) Loss	- -	- -	- -	- -	4	4	-8	1	- -	1	3	4	12	3	- -
+ Interest Expense, Net	- -	- -	- -	- -	- -	1	- -	1	- -	1	3	4	4	1	1
+ Interest Expense	- -	- -	- -	- -	- -	1	- -	1	- -	1	3	4	4	1	1
- Interest Income	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Non-Op (Income) Loss	- -	- -	- -	- -	3	4	-9	- -	- -	- -	- -	- -	8	2	-1
Pretax Income	-2	-2	-2	-3	-7	-8	3	-6	-12	-20	-37	-49	-42	-22	-22
- Income Tax Expense (Benefit)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	-2	-2	-2	-3	-6	-8	3	-6	-12	-20	-37	-50	-43	-22	-22
- Net Extraordinary Losses (Gains)	- -	- -	- -	-3	-1	- -	- -	- -	- -	- -	- -	1	1	- -	- -
+ Discontinued Operations	- -	- -	- -	3	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	-5	-1	- -	- -	- -	- -	- -	- -	1	1	- -	- -
Income (Loss) Incl. MI	-2	-2	-2	-1	-6	-8	3	-6	-12	-20	-37	-51	-43	-22	-22
- Minority Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1	-1	- -	- -
Net Income, GAAP	-2	-2	-2	-1	-6	-8	3	-6	-12	-20	-37	-50	-43	-22	-22
- Preferred Dividends	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4	5
- Other Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-2	-2	-2	-1	-6	-8	3	-6	-12	-20	-37	-50	-43	-26	-27
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	10
Basic EPS, GAAP	-63,972.97	-52,432.43	-43,945.95	-13,648.65	-155,621.62	-209,675	22,429.49	-2,744.23	-2,474.31	-2,180.76	-2,112.43	-1,609.23	-343.84	-16.56	-2.65
Basic EPS from Cont Ops	-63,972.97	-52,432.43	-43,945.95	-84,027.03	-175,621.62	-209,675	22,429.49	-2,744.23	-2,474.31	-2,180.76	-2,112.43	-1,609.23	-340.8	-13.93	-2.18
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	10
Diluted EPS, GAAP	-63,972.97	-52,432.43	-43,945.95	-13,648.65	-155,621.62	-209,675	22,429.49	-2,744.23	-2,474.31	-2,180.76	-2,112.43	-1,609.23	-343.84	-16.56	-2.65
Diluted EPS from Cont Ops	-63,972.97	-52,432.43	-43,945.95	-84,027.03	-175,621.62	-209,675	22,429.49	-2,744.23	-2,474.31	-2,180.76	-2,112.43	-1,609.23	-340.8	-13.93	-2.18
EBITDA	-3	-2	-2	-3	-3	-4	-5	-6	-12	-19	-33	-44	-29	-17	-20
EBITDA Margin (%)	-44.94	-36.85	-32.54	-539.18	-507.15	-377.96	-365.07	-6,228.89	-823.29	-260.37	-217.69	-238.59	-437.87	-313.89	-317.68
EBITA	-3	-2	-2	-3	-3	-4	-5	-6	-12	-19	-34	-45	-30	-18	-22
EBIT	-3	-2	-2	-3	-3	-4	-5	-6	-12	-19	-34	-45	-30	-18	-22
Gross Margin (%)	56.11	58.72	55.47	-11.75	36.51	49.91	58.32	44.44	31.93	35.42	48.69	39.53	15.47	5.4	9.65
Operating Margin (%)	-46.75	-39.57	-34.58	-546.34	-508.49	-381.94	-369.23	-6,291.11	-828.61	-261.92	-220.63	-242.83	-455.87	-337.56	-335.4
Profit Margin (%)	-39.42	-36.4	-34.51	-86.03	-858.12	-776.57	274.65	-6,866.67	-858.74	-281.63	-241.75	-269.92	-647.57	-399.98	-342.78
Sales per Employee	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Depreciation Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	1

Balance Sheet	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y
Total Current Assets	11	8	5	3	4	1	2	2	11	14	32	42	22	12	22
+ Cash, Cash Equivalents & STI	8	5	3	1	3	- -	1	1	7	8	21	30	13	7	19
+ Cash & Cash Equivalents	8	5	3	1	3	- -	1	1	7	8	21	30	13	7	19
+ ST Investments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Accounts & Notes Receiv	1	1	1	- -	- -	- -	1	- -	1	2	6	6	2	1	1
+ Accounts Receivable, Net	1	1	1	- -	- -	- -	1	- -	1	2	6	6	2	1	1
+ Notes Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Inventories	1	1	1	- -	- -	- -	- -	- -	2	3	2	4	5	3	1
+ Raw Materials	1	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	- -	- -
+ Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	4	3	1
+ Inventory Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	2	3	2	- -	- -	- -	- -
+ Other ST Assets	1	1	1	1	- -	- -	- -	1	1	1	3	3	2	1	1
+ Misc ST Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Noncurrent Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	4	5	5	5	4
+ Property, Plant & Equip, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	3	3	3	2
+ Property, Plant & Equip	2	2	2	1	1	1	1	- -	1	1	2	4	5	6	4
- Accumulated Depreciation	2	2	2	1	1	1	1	- -	- -	- -	1	2	2	3	3
+ LT Investments & Receivables	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	2	1	1	1
+ LT Investments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	2	1	1	1
+ LT Receivables	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other LT Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	2
+ Total Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	2
Total Assets	11	8	5	3	4	1	2	2	11	15	36	47	27	17	26
+ Payables & Accruals	2	1	1	1	- -	1	1	1	2	4	9	10	5	3	4
+ Accounts Payable	1	- -	- -	- -	- -	- -	- -	- -	1	3

Viveve Medical, Inc.

Income Statement

Balance Sheet